Independent Franchise Partners’s Zimmer Biomet ZBH Stock Holding History

Independent Franchise Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,523,749	Closed	-$268M	–	21
2015 Q2	$268M	Sell	2,523,749 -38,416	-1%	-$4.25M	3.16%	16
2015 Q1	$292M	Sell	2,562,165 -18,176	-0.7%	-$2.07M	3.58%	16
2014 Q4	$284M	Buy	2,580,341 +25,580	+1%	+$2.7M	3.76%	14
2014 Q3	$249M	Sell	2,554,761 -816,599	-24%	-$80.3M	3.46%	15
2014 Q2	$340M	Sell	3,371,360 -204,267	-6%	-$19.9M	5.18%	11
2014 Q1	$328M	Sell	3,575,627 -40,569	-1%	-$3.74M	5.36%	10
2013 Q4	$327M	Buy	3,616,196 +109,765	+3%	+$9.5M	5.2%	11
2013 Q3	$280M	Buy	3,506,431 +899,504	+35%	+$70.8M	4.74%	11
2013 Q2	$190M	Buy	+2,606,927	New	+$195M	3.62%	17

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Independent Franchise Partners's ZBH Position: Q3 2015 in Review

Independent Franchise Partners sold out of Zimmer Biomet (ZBH) in Q3 2015, closing a stake of 2,523,749 shares — an estimated $268M sold.

Independent Franchise Partners first reported a position in ZBH in Q2 2013 and held it in 9 quarters. The position peaked at $340M in Q2 2014. 726 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

Independent Franchise Partners reported no remaining Zimmer Biomet position as of Q3 2015 after selling out during the quarter.
Independent Franchise Partners sold 2,523,749 Zimmer Biomet shares in Q3 2015, an estimated $268M.
Independent Franchise Partners first reported a position in Zimmer Biomet in Q2 2013 and held it in 9 quarters.
Independent Franchise Partners's Zimmer Biomet position peaked at $340M in Q2 2014.
726 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Independent Franchise Partners's 13F filing for Q3 2015, filed 3 Nov 2015.